The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 5
  • 1
    Lewis, Samuel Emmanuel
    Certified Chartered Accountant born in December 1986
    Individual (5 offsprings)
    Officer
    2020-04-22 ~ now
    OF - Director → CIF 0
    Mr Samuel Emmanuel Lewis
    Born in December 1986
    Individual (5 offsprings)
    Person with significant control
    2020-08-28 ~ now
    PE - Has significant influence or controlCIF 0
  • 2
    Jarry, Ivan
    Investor Director born in May 1977
    Individual (1 offspring)
    Officer
    2025-01-30 ~ now
    OF - Director → CIF 0
  • 3
    Dr. Henry Alexander Fisher
    Born in July 1988
    Individual (3 offsprings)
    Person with significant control
    2020-08-28 ~ now
    PE - Has significant influence or controlCIF 0
  • 4
    Mcdonald, Thomas Rory
    Management Consultant born in March 1986
    Individual (2 offsprings)
    Officer
    2020-10-20 ~ now
    OF - Director → CIF 0
    Mr Thomas Rory Mcdonald
    Born in March 1986
    Individual (2 offsprings)
    Person with significant control
    2020-08-28 ~ now
    PE - Has significant influence or controlCIF 0
  • 5
    Mr George Timothy Fergus Mcbride
    Born in July 1987
    Individual (5 offsprings)
    Person with significant control
    2020-08-28 ~ now
    PE - Has significant influence or controlCIF 0
Ceased 4
  • 1
    Fratacci, Thomas Mathieu
    Investor Director born in December 1976
    Individual
    Officer
    2024-05-16 ~ 2025-01-30
    OF - Director → CIF 0
  • 2
    Moore, Alastair John
    Marketing Director born in July 1989
    Individual (5 offsprings)
    Officer
    2020-10-20 ~ 2022-03-31
    OF - Director → CIF 0
    Mr Alastair Moore
    Born in July 1989
    Individual (5 offsprings)
    Person with significant control
    2020-08-28 ~ 2021-08-16
    PE - Has significant influence or controlCIF 0
  • 3
    Fisher, Henry
    Scientist born in July 1987
    Individual (3 offsprings)
    Officer
    2020-10-20 ~ 2022-03-31
    OF - Director → CIF 0
  • 4
    Mcbride, George Timothy Fergus
    Barrister born in July 1987
    Individual (5 offsprings)
    Officer
    2020-10-22 ~ 2022-03-31
    OF - Director → CIF 0
parent relation
Company in focus

CLERKENWELL CLINICS LIMITED

Standard Industrial Classification
86900 - Other Human Health Activities
Brief company account
Par Value of Share
Class 1 ordinary share
02023-01-01 ~ 2023-12-31
Class 2 ordinary share
02023-01-01 ~ 2023-12-31
Intangible Assets
34,669 GBP2023-12-31
34,822 GBP2022-12-31
Property, Plant & Equipment
82,707 GBP2023-12-31
91,820 GBP2022-12-31
Fixed Assets
117,376 GBP2023-12-31
126,642 GBP2022-12-31
Total Inventories
59,305 GBP2022-12-31
Debtors
221,940 GBP2023-12-31
142,565 GBP2022-12-31
Cash at bank and in hand
75,898 GBP2023-12-31
595,283 GBP2022-12-31
Current Assets
297,838 GBP2023-12-31
797,153 GBP2022-12-31
Creditors
Current
369,776 GBP2023-12-31
208,524 GBP2022-12-31
Net Current Assets/Liabilities
-71,938 GBP2023-12-31
588,629 GBP2022-12-31
Total Assets Less Current Liabilities
45,438 GBP2023-12-31
715,271 GBP2022-12-31
Creditors
Non-current
843,981 GBP2023-12-31
72,553 GBP2022-12-31
Net Assets/Liabilities
-798,543 GBP2023-12-31
642,718 GBP2022-12-31
Equity
Called up share capital
84 GBP2023-12-31
84 GBP2022-12-31
Share premium
2,459,861 GBP2023-12-31
2,459,861 GBP2022-12-31
Retained earnings (accumulated losses)
-3,258,488 GBP2023-12-31
-1,817,227 GBP2022-12-31
Equity
-798,543 GBP2023-12-31
642,718 GBP2022-12-31
Average Number of Employees
202023-01-01 ~ 2023-12-31
122022-01-01 ~ 2022-12-31
Intangible Assets - Gross Cost
42,820 GBP2023-12-31
38,691 GBP2022-12-31
Intangible Assets - Accumulated Amortisation & Impairment
8,151 GBP2023-12-31
3,869 GBP2022-12-31
Intangible Assets - Increase From Amortisation Charge for Year
4,282 GBP2023-01-01 ~ 2023-12-31
Property, Plant & Equipment - Gross Cost
149,977 GBP2023-12-31
122,986 GBP2022-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
67,270 GBP2023-12-31
31,166 GBP2022-12-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
36,104 GBP2023-01-01 ~ 2023-12-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
686,040 shares2023-12-31
Class 2 ordinary share
151,092 shares2023-12-31

  • CLERKENWELL CLINICS LIMITED
    Info
    Registered number 12568155
    39 Welbeck Street, London W1G 8DR
    Private Limited Company incorporated on 2020-04-22 (5 years 2 months). The company status is Active.
    The last date of confirmation statement was made at 2024-08-31
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.
© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.